Total Funding
12
Total FundingGrant raised
Growth Score in past quarter
pts
Heat Score 12 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
249938
AVX Pharma is a biopharmaceutical company focused on developing novel drugs addressing major ophthalmic unmet medical needs
- Carlos Belmonte: Founder
About the Company
AVX Pharma is a biopharmaceutical company focused on developing novel drugs addressing major ophthalmic unmet medical needs, with especial focus on ocular surface diseases.
The company was founded in July 2013 on the grounds of neurobiological research performed by the Group on Ocular Sensory Innervation led by Prof. Carlos Belmonte at the
Instituto de Neurociencias de Alicante, and its operations are carried from Barcelona.


